Drug
Fate Nk100
Fate Nk100: highest development phase Phase 1, developed by Fate Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fate Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| FATE-NK100 NCT03319459 | Phase 1 | HER2 Positive Gastric Cancer |
Latest
No recent events.
Follow Fate Nk100 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.